The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities

Over the past several years, tumor necrosis factor (TNF) antagonists have become first-line agents in the treatment of moderate-to-severe psoriasis. These medications are highly effective in treating both psoriasis and psoriatic arthritis and may also reduce the risk of cardiovascular events in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Yost, John, Gudjonsson, Johann E
Formato: Texto
Lenguaje:English
Publicado: Medicine Reports Ltd 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924720/
https://www.ncbi.nlm.nih.gov/pubmed/20948750
http://dx.doi.org/10.3410/M1-30
_version_ 1782185622853648384
author Yost, John
Gudjonsson, Johann E
author_facet Yost, John
Gudjonsson, Johann E
author_sort Yost, John
collection PubMed
description Over the past several years, tumor necrosis factor (TNF) antagonists have become first-line agents in the treatment of moderate-to-severe psoriasis. These medications are highly effective in treating both psoriasis and psoriatic arthritis and may also reduce the risk of cardiovascular events in patients with chronic inflammatory disorders. In this article we review the use of anti-TNF therapy in psoriasis and its implications in regards to the co-morbid conditions associated with psoriasis.
format Text
id pubmed-2924720
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medicine Reports Ltd
record_format MEDLINE/PubMed
spelling pubmed-29247202010-10-14 The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities Yost, John Gudjonsson, Johann E F1000 Med Rep Review Article Over the past several years, tumor necrosis factor (TNF) antagonists have become first-line agents in the treatment of moderate-to-severe psoriasis. These medications are highly effective in treating both psoriasis and psoriatic arthritis and may also reduce the risk of cardiovascular events in patients with chronic inflammatory disorders. In this article we review the use of anti-TNF therapy in psoriasis and its implications in regards to the co-morbid conditions associated with psoriasis. Medicine Reports Ltd 2009-05-08 /pmc/articles/PMC2924720/ /pubmed/20948750 http://dx.doi.org/10.3410/M1-30 Text en © 2009 Medicine Reports Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Yost, John
Gudjonsson, Johann E
The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities
title The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities
title_full The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities
title_fullStr The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities
title_full_unstemmed The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities
title_short The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities
title_sort role of tnf inhibitors in psoriasis therapy: new implications for associated comorbidities
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924720/
https://www.ncbi.nlm.nih.gov/pubmed/20948750
http://dx.doi.org/10.3410/M1-30
work_keys_str_mv AT yostjohn theroleoftnfinhibitorsinpsoriasistherapynewimplicationsforassociatedcomorbidities
AT gudjonssonjohanne theroleoftnfinhibitorsinpsoriasistherapynewimplicationsforassociatedcomorbidities
AT yostjohn roleoftnfinhibitorsinpsoriasistherapynewimplicationsforassociatedcomorbidities
AT gudjonssonjohanne roleoftnfinhibitorsinpsoriasistherapynewimplicationsforassociatedcomorbidities

Ejemplares similares